A detailed history of Ica Group Wealth Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Ica Group Wealth Management, LLC holds 70 shares of MRNA stock, worth $8,282. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70
Previous 70 -0.0%
Holding current value
$8,282
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Mar 07, 2024

BUY
$69.51 - $104.43 $4,865 - $7,310
70 New
70 $6,000
Q1 2023

May 12, 2023

SELL
$135.66 - $197.02 $4,069 - $5,910
-30 Reduced 19.74%
122 $18,000
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $17,993 - $31,926
152 New
152 $27,000
Q2 2022

Oct 03, 2022

BUY
$117.13 - $176.59 $167,964 - $253,230
1,434 New
1,434 $210,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ica Group Wealth Management, LLC Portfolio

Follow Ica Group Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ica Group Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ica Group Wealth Management, LLC with notifications on news.